Mesoblast Ltd

MESO NASDAQ Santé & Biotech Monde US5907174016
13.95 $
6.56 %

Mesoblast Ltd est engagée dans le développement de thérapies cellulaires régénératives traitant des maladies inflammatoires graves.

Performance & Momentum

6 Months 16.45 %
1 Year 28.60 %
3 Years 103.96 %
5 Years 3.39 %

Similar stocks to Mesoblast Ltd

Anantys Community

Be the first to share your analysis on Mesoblast Ltd.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases